Payers

Latest News

Should Payers Incentivize Pharmacies to Blister-Package Chronic Medications?
Should Payers Incentivize Pharmacies to Blister-Package Chronic Medications?

June 2nd 2025

Payers should consider providing higher reimbursement rates and/or preferred pharmacy networking status for pharmacies that provide chronic medications in blister packs for patients.

Based on western blot testing, patients who received gene therapy at 2 years old showed a mean dystrophin expression of 93.87% of normal. | Image Credit: Treecha - stock.adobe.com
DMD Gene Therapy Shows Efficacy, Safety in Patients Treated at 2 Years Old

May 23rd 2025

The new report highlights several barriers to CGT use, including cumbersome referral processes, high price tags, complex logistics, and uncertainties around reimbursement. | Image Credit: Treecha - stock.adobe.com
CGTs Have Potential to Transform Care, but Challenges Persist

May 14th 2025

Quantitative magnetic resonance imaging seemed to show that delandistrogene moxeparvovec protects muscle from progressive damage in DMD. | Image credit: OlegKachura - stock.adobe.com
Quantitative Magnetic Resonance Outcomes Suggest Gene Therapy Slows DMD Progression

May 14th 2025

AJMC
Using Data Exchange to Improve Quality Reporting, Target Outreach, and Reduce Cost

May 13th 2025

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo